| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Revenue: | ||||||
Revenue, net of contractual allowances and discounts | ||||||
- | 361,053 | |||||
Provision for doubtful accounts | ||||||
- | 15,775 | |||||
Net revenue | ||||||
529,644 | 345,278 | |||||
Costs and expenses: | ||||||
Cost of net revenue | ||||||
440,386 | 293,384 | |||||
General and administrative expenses | ||||||
56,492 | 18,068 | |||||
Depreciation, excluding patient equipment depreciation | ||||||
3,068 | 2,733 | |||||
Total costs and expenses | ||||||
499,947 | 314,187 | |||||
Operating income | ||||||
29,696 | 31,091 | |||||
Interest expense, net | ||||||
39,304 | 7,452 | |||||
Loss on extinguishment of debt | ||||||
-2,121 | -1,398 | |||||
Income (loss) before income taxes | ||||||
-11,729 | 22,239 | |||||
Income tax expense | ||||||
1,156 | -2,097 | |||||
Net income (loss) | ||||||
-12,885 | 24,337 | |||||
Income attributable to noncontrolling interest | ||||||
2,110 | 1,076 | |||||
Net loss attributable to AdaptHealth Corp. | ||||||
-14,995 | 23,260 | |||||
Net loss per common share: | ||||||
Basic and diluted (per share) | ||||||
-0.66 | 1.95 | |||||
Weighted average shares outstanding for net loss attributable to AdaptHealth Corp.: | ||||||
Basic and diluted (shares) | ||||||
22,557 | 11,899 | |||||